Navigation Links
UCI study finds specific genetic cue for sudden cardiac death syndrome
Date:2/18/2014

Irvine, Calif., Feb. 18, 2014 UC Irvine researchers have found a specific genetic flaw that is connected to sudden death due to heart arrhythmia a leading cause of mortality for adults around the world.

While a number of genes have been linked with arrhythmias, UC Irvine's Geoffrey Abbott and his colleagues discovered that the functional impairment of a gene called KCNE2 underlies a multisystem syndrome that affects both heart rhythm and blood flow and can activate chemical triggers that can cause sudden cardiac death.

"With these findings, we can now explore improved early detection and prevention strategies for people who are at higher risk of sudden cardiac death, such as those with diabetes," said Abbott, a professor of pharmacology and physiology & biophysics in the UC Irvine School of Medicine.

Study results appear in the February issue of Circulation: Cardiovascular Genetics, a publication of the American Heart Association.

Distinct from a heart attack, in which the heart continues to beat but blood flow is blocked, sudden cardiac death occurs when the heart ceases to beat because of the uncontrolled twitching of muscle fibers in its ventricles. Without defibrillation within minutes, this type of event is fatal.

In studies on a mouse model with the KCNE2 gene removed, Abbott and his colleagues had found catalysts for sudden cardiac death including high blood cholesterol, anemia, high blood potassium, an age-related delay in the return to a resting position of the ventricle after contraction and, most surprisingly, diabetes.

Abbott said this link to diabetes and other systemic disturbances is significant because genes such as KCNE2 are better known for directly controlling the electrical signaling that ensures a steady heartbeat. The KCNE2 gene provides instructions for making a protein that regulates the activity of potassium channels, which play a key role in a cell's ability to generate and transmit electrical signals. Channels regulated by the KCNE2 protein are present in heart muscles and help recharge them after each heartbeat to maintain a regular rhythm.

In the current study, the researchers expanded on their previous work by showing that KCNE2 disruptions affect these rhythms in cardiac cells, which increases the risk of arrhythmia. Abbott said the major breakthrough in this study is that KCNE2 deletion could adversely affect so many other tissues outside the heart and that this dramatically worsened the outcome of cardiac electrical disturbances.

"Our discovery that a single gene disruption can give rise to a multitissue syndrome that predisposes one to sudden cardiac death challenges the established thinking that this type of genetic disruption can only give rise to a single component, such as abnormal electrical signaling in cardiac cells," Abbott said.

He pointed out that the use of full-gene knockout mice presents an exaggerated form of what occurs in human genetic syndromes.

"It's important to note that the mouse heart is very resistant to developing ventricular fibrillation," he said. "So the fact that we kept seeing this arrhythmia in the KCNE2-deleted mice gives us confidence that these findings are significant. We're currently using the same mouse model to investigate the mechanisms of myocardial infarction, another major cause of mortality recently associated with the KCNE2 gene."

The gene's relationship to diabetes is another area Abbott's group is exploring. He said that one of the potassium channels regulated by KCNE2 is strongly linked to human diabetes and is present in the islet cells of the pancreas, so one goal is to screen people with diabetes for DNA sequence variances in KCNE2.


'/>"/>
Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related biology news :

1. U of M study finds fertilization destabilizes global grassland ecosystems
2. Worldwide study finds that fertilizer destabilizes grasslands
3. Study on flu evolution may change textbooks, history books
4. University of Guelph study assesses environmental impact of Ontario corn production
5. Neimark Award winners study statistics, chemistry, plant sciences, astrophysics and linguistics
6. Dartmouth study shows US Southwest irrigation system facing decline after 4 centuries
7. Study: IOC should ban lead shot to help wildlife, water
8. UTMB study examines hospital readmission rates after inpatient rehabilitation
9. TGen study uncovers possible genetic markers in breast cancer that spreads to the brain
10. Study involving twin sisters provides clues for battling aggressive cancers
11. Social or stinky? New study reveals how animal defenses evolve
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/6/2017)... 2017 According to Acuity Market Intelligence, ... authorities to continue to embrace biometric and digital ... Automated Border Control (ABC) eGates and 1436 Automated ... than 163 ports of entry across the globe. ... a combined CAGR of 37%. APC Kiosks reached ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... Dublin - Research and Markets has announced ... Type, By Application, By End User, By Region, By Country: Opportunities ... ... is forecasted to grow at a CAGR of 11.33% during 2016-2021. ... protection market is driven by the surging demand for less toxic ...
(Date:2/22/2017)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), ... the ability of the Aethlon Hemopurifier® to capture latent ... immune-suppressed sepsis patients and also contribute to organ rejection ... the study was to validate the in vitro ... Herpes Simplex virus 1 (HSV1) by the Hemopurifier®. The ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... announced the addition of Tom Perkins as European director. Operating from Pennside’s Zurich ... to Pennside. , Perkins joins Pennside after more than a decade with ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
Breaking Biology Technology: